Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study.

Klein NP, Abu-Elyazeed R, Povey M, Macias Parra M, Diez-Domingo J, Ahonen A, Korhonen T, Tinoco JC, Weiner L, Marshall GS, Silas PE, Sarpong KO, Ramsey KP, Fling JA, Speicher D, Campos M, Munjal I, Peltier C, Vesikari T, Baccarini C, Caplanusi A, Gillard P, Carryn S, Henry O.

J Pediatric Infect Dis Soc. 2019 Mar 8. pii: piz010. doi: 10.1093/jpids/piz010. [Epub ahead of print]

PMID:
30849175
2.

Antimicrobial susceptibility of gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).

Ponce-de-Leon A, Rodríguez-Noriega E, Morfín-Otero R, Cornejo-Juárez DP, Tinoco JC, Martínez-Gamboa A, Gaona-Tapia CJ, Guerrero-Almeida ML, Martin-Onraët A, Vallejo Cervantes JL, Sifuentes-Osornio J.

PLoS One. 2018 Jun 21;13(6):e0198621. doi: 10.1371/journal.pone.0198621. eCollection 2018.

3.

Respiratory viruses and influenza-like illness: Epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample.

Taylor S, Lopez P, Weckx L, Borja-Tabora C, Ulloa-Gutierrez R, Lazcano-Ponce E, Kerdpanich A, Angel Rodriguez Weber M, Mascareñas de Los Santos A, Tinoco JC, Safadi MA, Lim FS, Hernandez-de Mezerville M, Faingezicht I, Cruz-Valdez A, Feng Y, Li P, Durviaux S, Haars G, Roy-Ghanta S, Vaughn DW, Nolan T.

J Infect. 2017 Jan;74(1):29-41. doi: 10.1016/j.jinf.2016.09.003. Epub 2016 Sep 22.

PMID:
27667752
4.

Prevalence and Incidence of Respiratory Syncytial Virus and Other Respiratory Viral Infections in Children Aged 6 Months to 10 Years With Influenza-like Illness Enrolled in a Randomized Trial.

Nolan T, Borja-Tabora C, Lopez P, Weckx L, Ulloa-Gutierrez R, Lazcano-Ponce E, Kerdpanich A, Weber MA, Mascareñas de Los Santos A, Tinoco JC, Safadi MA, Seng LF, Hernandez-de Mezerville M, Faingezicht I, Cruz-Valdez A, Feng Y, Li P, Durviaux S, Haars G, Roy-Ghanta S, Vaughn DW, Taylor S.

Clin Infect Dis. 2015 Jun 1;60(11):e80-9. doi: 10.1093/cid/civ065. Epub 2015 Feb 11.

5.

Open-label trial of immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults ≥ 50 years of age in Mexico.

Tinoco JC, Juergens C, Ruiz Palacios GM, Vazquez-Narvaez J, Enkerlin-Pauwells HL, Sundaraiyer V, Pathirana S, Kalinina E, Gruber WC, Scott DA, Schmoele-Thoma B.

Clin Vaccine Immunol. 2015 Feb;22(2):185-92. doi: 10.1128/CVI.00711-14. Epub 2014 Dec 10.

6.

Relative efficacy of AS03-adjuvanted pandemic influenza A(H1N1) vaccine in children: results of a controlled, randomized efficacy trial.

Nolan T, Roy-Ghanta S, Montellano M, Weckx L, Ulloa-Gutierrez R, Lazcano-Ponce E, Kerdpanich A, Safadi MA, Cruz-Valdez A, Litao S, Lim FS, de Los Santos AM, Weber MA, Tinoco JC, Mezerville MH, Faingezicht I, Kosuwon P, Lopez P, Borja-Tabora C, Li P, Durviaux S, Fries L, Dubin G, Breuer T, Innis BL, Vaughn DW.

J Infect Dis. 2014 Aug 15;210(4):545-57. doi: 10.1093/infdis/jiu173. Epub 2014 Mar 20.

7.

Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: a phase III, randomized trial.

Tinoco JC, Pavia-Ruz N, Cruz-Valdez A, Aranza Doniz C, Chandrasekaran V, Dewé W, Liu A, Innis BL, Jain VK.

Vaccine. 2014 Mar 14;32(13):1480-7. doi: 10.1016/j.vaccine.2014.01.022. Epub 2014 Jan 28.

8.

Virulence and antibiotic resistance of Enterococcus faecalis clinical isolates recovered from three states of Mexico. Detection of linezolid resistance.

López-Salas P, Llaca-Díaz J, Morfin-Otero R, Tinoco JC, Rodriguez-Noriega E, Salcido-Gutierres L, González GM, Mendoza-Olazarán S, Garza-González E.

Arch Med Res. 2013 Aug;44(6):422-8. doi: 10.1016/j.arcmed.2013.07.003. Epub 2013 Aug 22.

PMID:
23973462
9.

Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance study.

González GM, Treviño-Rangel Rde J, Palma-Nicolás JP, Martínez C, González JG, Ayala J, Caballero A, Morfín-Otero R, Rodríguez-Noriega E, Velarde F, Ascencio EP, Tinoco JC, Vázquez JA, Cano MA, León-Sicairos N, González R, Rincón J, Elías MA, Bonifaz A.

J Antimicrob Chemother. 2013 Dec;68(12):2847-51. doi: 10.1093/jac/dkt283. Epub 2013 Jul 18.

PMID:
23869052
10.

Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains isolated from invasive and non-invasive infections from Mexico and the USA during 1999-2010.

Villaseñor-Sierra A, Katahira E, Jaramillo-Valdivia AN, Barajas-García Mde L, Bryant A, Morfín-Otero R, Márquez-Díaz F, Tinoco JC, Sánchez-Corona J, Stevens DL.

Int J Infect Dis. 2012 Mar;16(3):e178-81. doi: 10.1016/j.ijid.2011.11.005. Epub 2012 Jan 2.

11.

Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.

Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, López P, Macías-Parra M, Ortega-Barría E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavía-Ruz N, Salmerón J, Rüttimann R, Tinoco JC, Rubio P, Nuñez E, Guerrero ML, Yarzábal JP, Damaso S, Tornieporth N, Sáez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, De Vos B, O'Ryan M; Human Rotavirus Vaccine Study Group.

N Engl J Med. 2006 Jan 5;354(1):11-22.

12.

Nosocomial bacteremia and urinary tract infections caused by extended-spectrum beta -lactamase-producing Klebsiella pneumoniae with plasmids carrying both SHV-5 and TLA-1 genes.

Alcantar-Curiel D, Tinoco JC, Gayosso C, Carlos A, Daza C, Perez-Prado MC, Salcido L, Santos JI, Alpuche-Aranda CM.

Clin Infect Dis. 2004 Apr 15;38(8):1067-74. Epub 2004 Mar 24.

PMID:
15095209
13.

Outbreak of nosocomial sepsis and pneumonia in a newborn intensive care unit by multiresistant extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: high impact on mortality.

Martinez-Aguilar G, Alpuche-Aranda CM, Anaya C, Alcantar-Curiel D, Gayosso C, Daza C, Mijares C, Tinoco JC, Santos JI.

Infect Control Hosp Epidemiol. 2001 Nov;22(11):725-8.

PMID:
11842997
14.

Clinical and bacteriologic efficacy of amoxycillin b.d. (45 mg/kg/day) versus amoxycillin t.d.s (40 mg/kg/day) in children with group A beta-hemolytic streptococcal tonsillopharyngitis.

Aguilar A, Tinoco JC, Macias M, Huicho L, Levy J, Trujillo H, Lopez P, Pereira M, Maqbool S, Bhutta ZA, Sacy RA, Deacon S.

J Chemother. 2000 Oct;12(5):396-405.

PMID:
11128559
15.

[Epidemiology of nosocomial infections in a second level hospital].

Tinoco JC, Salvador-Moysen J, Pérez-Prado MC, Santillán-Martínez G, Salcido-Gutiérrez L.

Salud Publica Mex. 1997 Jan-Feb;39(1):25-31. Spanish.

PMID:
9092095
16.

[Nosocomial urinary tract infections at a second-level hospital].

Tinoco JC, Hernández-Ruiz E, Salvador-Moysen J, Rivera-Morales I.

Salud Publica Mex. 1994 Jan-Feb;36(1):17-21. Spanish.

PMID:
8042066
17.

[Endoscopy for the patient with AIDS].

Gallo Reynoso S, Ponce de León S, Tinoco JC, Valdovinos MA.

Rev Gastroenterol Mex. 1987 Apr-Jun;52(2):133-5. Spanish. No abstract available.

PMID:
3629112
18.

[Features of the acquired immunodeficiency syndrome in 93 patients at the Instituto Nacional de la Nutrición "Salvador Zubirán"].

Ruiz-Palacios GM, Ponce de León S, Cruz López A, Tinoco JC, Schnieders B, Macías A, Ortiz E, Valpuesta V, Nares F.

Rev Invest Clin. 1987;39 Suppl:7-12. Spanish. No abstract available.

PMID:
3482720
19.

[Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].

Sierra Madero JG, Ponce de León S, Ruiz Palacios G, Tinoco JC, Calva JJ, Zamora EE.

Salud Publica Mex. 1986 Mar-Apr;28(2):180-5. Spanish. No abstract available.

PMID:
3014666

Supplemental Content

Loading ...
Support Center